A clinical study of transdermal contraceptive patch in Thai adolescence women
- PMID: 18389975
A clinical study of transdermal contraceptive patch in Thai adolescence women
Abstract
Objective: To study cycle control, compliance and safety of a transdermal contraceptive patch in adolescent Thai women.
Material and method: Fifty-eight healthy women were assigned to receive 3 cycles of contraceptive patch (ethinyl estradiol 20 microg and norelgestromin 150 microg/day). All participants aged 16-20 years were invited to participate from the family planning clinic at King Chulalongkorn Memorial Hospital. Data were collected on adverse effects, perceived advantages and disadvantages, body weight, blood pressure, patch detachments and compliance. Data were analyzed using mean, percentage and student's t-test.
Results: The participants' average age was 19.4 years, height 158.8 cm, weight 51.8 kg, BMI 20.8 Kg/m2. The most location of patch application was the abdomen and the most adverse event was breast tenderness (31.0%) followed by application site reaction, nausea vomiting and headache respectively. The breast symptom was mild in severity. The participants reported decrease in dysmenorrhea and shorter duration of bleeding. There were no significant changes in body weight and blood pressure. The improvement of their facial acne was reported. There were no pregnancies during use and the adhesion of the contraceptive patch is excellent. Partial patch detachment was reported in only 6.9%. No completed patch detachment was found.
Conclusion: The present study found an overall positive impression of a new transdermal contraceptive patch. The good compliance and few side effects were demonstrated. The adhesive patch contraceptive was excellent.
Similar articles
-
A clinical study of transdermal contraceptive patch in Thai women.J Med Assoc Thai. 2006 Oct;89 Suppl 4:S1-4. J Med Assoc Thai. 2006. PMID: 17726805
-
Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.J Pediatr Adolesc Gynecol. 2005 Apr;18(2):85-90. doi: 10.1016/j.jpag.2004.11.016. J Pediatr Adolesc Gynecol. 2005. PMID: 15897103
-
An evaluation of the use of the transdermal contraceptive patch in adolescents.J Adolesc Health. 2004 May;34(5):395-401. doi: 10.1016/j.jadohealth.2003.08.017. J Adolesc Health. 2004. PMID: 15093794 Clinical Trial.
-
The transdermal contraceptive patch: a new approach to hormonal contraception.Int J Fertil Womens Med. 2002 Mar-Apr;47(2):69-76. Int J Fertil Womens Med. 2002. PMID: 11991433 Review.
-
Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.Treat Endocrinol. 2003;2(3):191-206. doi: 10.2165/00024677-200302030-00005. Treat Endocrinol. 2003. PMID: 15966567 Review.
Cited by
-
Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review.Patient Prefer Adherence. 2008 Feb 2;2:357-67. doi: 10.2147/ppa.s3233. Patient Prefer Adherence. 2008. PMID: 19920983 Free PMC article.
-
Hormonal Contraceptives and Dermatology.Am J Clin Dermatol. 2021 Jan;22(1):69-80. doi: 10.1007/s40257-020-00557-5. Am J Clin Dermatol. 2021. PMID: 32894455 Review.